Using an in vitro complementation approach to model inter-clonal tumor cell interactions, we find that IL-6 secreted by HER2neg and IL-6 unresponsive IBC cells drives proliferation of HER2pos and IL-6R-expressing IBC cells. Here, IL6 is linked to inflammatory breast carcinoma.